Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 4 studies | 17% ± 1% | |
epithelial cell | 4 studies | 24% ± 6% | |
classical monocyte | 3 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 31% ± 7% | |
glutamatergic neuron | 3 studies | 40% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 26% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1501.63 | 459 / 459 | 100% | 20.95 | 1118 / 1118 |
esophagus | 100% | 1282.90 | 1445 / 1445 | 100% | 16.62 | 183 / 183 |
lung | 100% | 1596.59 | 578 / 578 | 100% | 12.38 | 1155 / 1155 |
ovary | 100% | 1068.47 | 180 / 180 | 100% | 8.46 | 430 / 430 |
prostate | 100% | 1151.58 | 245 / 245 | 100% | 10.62 | 502 / 502 |
bladder | 100% | 1279.29 | 21 / 21 | 100% | 10.52 | 503 / 504 |
brain | 100% | 1279.93 | 2635 / 2642 | 100% | 11.61 | 704 / 705 |
adrenal gland | 100% | 1414.79 | 258 / 258 | 100% | 8.58 | 229 / 230 |
kidney | 100% | 877.87 | 89 / 89 | 100% | 11.55 | 897 / 901 |
thymus | 100% | 1264.93 | 652 / 653 | 100% | 10.15 | 602 / 605 |
uterus | 100% | 1186.69 | 170 / 170 | 99% | 9.52 | 456 / 459 |
pancreas | 100% | 830.96 | 327 / 328 | 99% | 10.45 | 177 / 178 |
stomach | 100% | 1079.01 | 359 / 359 | 99% | 12.96 | 283 / 286 |
intestine | 100% | 1446.43 | 966 / 966 | 99% | 11.14 | 521 / 527 |
liver | 100% | 1100.68 | 226 / 226 | 99% | 7.55 | 400 / 406 |
skin | 100% | 1469.35 | 1808 / 1809 | 97% | 12.99 | 459 / 472 |
adipose | 100% | 1590.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1511.79 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.86 | 29 / 29 |
muscle | 100% | 1525.54 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2271.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.42 | 1 / 1 |
peripheral blood | 98% | 1975.12 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 759.44 | 831 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 10.55 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006974 | Biological process | DNA damage response |
GO_0016579 | Biological process | protein deubiquitination |
GO_0071108 | Biological process | protein K48-linked deubiquitination |
GO_0035871 | Biological process | protein K11-linked deubiquitination |
GO_1905634 | Biological process | regulation of protein localization to chromatin |
GO_0090168 | Biological process | Golgi reassembly |
GO_0016320 | Biological process | endoplasmic reticulum membrane fusion |
GO_0006508 | Biological process | proteolysis |
GO_0106300 | Biological process | protein-DNA covalent cross-linking repair |
GO_0005795 | Cellular component | Golgi stack |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | VCPIP1 |
Protein name | Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein) |
Synonyms | VCIP135 KIAA1850 |
Description | FUNCTION: Deubiquitinating enzyme involved in DNA repair and reassembly of the Golgi apparatus and the endoplasmic reticulum following mitosis . Necessary for VCP-mediated reassembly of Golgi stacks after mitosis (By similarity). Plays a role in VCP-mediated formation of transitional endoplasmic reticulum (tER) (By similarity). Mediates dissociation of the ternary complex containing STX5A, NSFL1C and VCP (By similarity). Also involved in DNA repair following phosphorylation by ATM or ATR: acts by catalyzing deubiquitination of SPRTN, thereby promoting SPRTN recruitment to chromatin and subsequent proteolytic cleavage of covalent DNA-protein cross-links (DPCs) . Hydrolyzes 'Lys-11'- and 'Lys-48'-linked polyubiquitin chains . .; FUNCTION: (Microbial infection) Regulates the duration of C.botulinum neurotoxin type A (BoNT/A) intoxication by catalyzing deubiquitination of Botulinum neurotoxin A light chain (LC), thereby preventing LC degradation by the proteasome, and accelerating botulinum neurotoxin intoxication in patients. . |
Accessions | ENST00000310421.5 Q96JH7 |